Cosmetic Compliance
Intelligence & Solutions
Home / News / Details

Japan Requires Mandatory Precautions on Packages for Quasi-Drugs Containing Chlorhexidine Gluconate

Japan stipulated that if chlorhexidine gluconate or chlorhexidine is used in quasi-drugs as an active ingredient, certain "use precautions" should be listed on the product container...

Takehome:

Japan stipulated that if chlorhexidine gluconate or chlorhexidine is used in quasi-drugs as an active ingredient, certain "use precautions" should be listed on the product container.

This decision addresses the allergy or shock (anaphylaxis) associated with chlorhexidine use. Normally this ingredient is used in outer skin disinfectants and scratch disinfectants. For those products, precautions should be added on containers or encapsulations as follows:

  1. Those who have allergy symptoms due to chlorhexidine please do not use this product;
  2. In rare cases, severe symptoms of shock (anaphylaxis) may occur. If urticarial lesion, breathlessness, loss of consciousness happened, please immediately stop using the product and visit the doctor as soon as possible; for people who have never experienced such symptoms, it is highly suggested to consult with a doctor before using.
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Copyright: unless otherwise stated all contents of this website are ©2024 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com